0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and United States Sexually Transmitted Disease Therapeutics Market Report & Forecast 2022-2028
Published Date: June 2022
|
Report Code: QYRE-Othe-412
Home | Market Reports | Health
Global and United States Sexually Transmitted Disease Therapeutics Market Report Forecast 2022 2028

Global and United States Sexually Transmitted Disease Therapeutics Market Report & Forecast 2022-2028

Code: QYRE-Othe-412
Report
June 2022
93 Pages
QYResearch
Region: North America, Europe, Asia Pacific, South America, Middle East, Africa, Global,
Description
Table of Content
Tables & Figures
Sexually transmitted diseases are infections that are passed from one person to another through sexual contact.
Market Analysis and Insights: Global and United States Sexually Transmitted Disease Therapeutics Market
This report focuses on global and United States Sexually Transmitted Disease Therapeutics market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Sexually Transmitted Disease Therapeutics market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, by Type, Gonorrhea accounting for % of the Sexually Transmitted Disease Therapeutics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While by Application, Hospitals was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the Sexually Transmitted Disease Therapeutics market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.

Global Sexually Transmitted Disease Therapeutics Scope and Market Size
Sexually Transmitted Disease Therapeutics market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Sexually Transmitted Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Sexually Transmitted Disease Therapeutics market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

Gonorrhea
Syphilis
Chlamydia
Trichomoniasis

Segment by Application

Hospitals
Diagnostic Laboratories
Research and Academic Laboratories
Others

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

BY COMPANY

Abbott
Roche
BD
BioMérieux
Bio-Rad
Cepheid
1 Study Coverage
1.1 Sexually Transmitted Disease Therapeutics Revenue in Sexually Transmitted Disease Therapeutics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Sexually Transmitted Disease Therapeutics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Sexually Transmitted Disease Therapeutics Market Size for the Year 2017-2028
1.2.2 Global Sexually Transmitted Disease Therapeutics Market Size for the Year 2017-2028
1.3 Sexually Transmitted Disease Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Sexually Transmitted Disease Therapeutics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Sexually Transmitted Disease Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Sexually Transmitted Disease Therapeutics Market Dynamics
1.4.1 Sexually Transmitted Disease Therapeutics Industry Trends
1.4.2 Sexually Transmitted Disease Therapeutics Market Drivers
1.4.3 Sexually Transmitted Disease Therapeutics Market Challenges
1.4.4 Sexually Transmitted Disease Therapeutics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Sexually Transmitted Disease Therapeutics by Type
2.1 Sexually Transmitted Disease Therapeutics Market Segment by Type
2.1.1 Gonorrhea
2.1.2 Syphilis
2.1.3 Chlamydia
2.1.4 Trichomoniasis
2.2 Global Sexually Transmitted Disease Therapeutics Market Size by Type (2017, 2022 & 2028)
2.3 Global Sexually Transmitted Disease Therapeutics Market Size by Type (2017-2028)
2.4 United States Sexually Transmitted Disease Therapeutics Market Size by Type (2017, 2022 & 2028)
2.5 United States Sexually Transmitted Disease Therapeutics Market Size by Type (2017-2028)
3 Sexually Transmitted Disease Therapeutics by Application
3.1 Sexually Transmitted Disease Therapeutics Market Segment by Application
3.1.1 Hospitals
3.1.2 Diagnostic Laboratories
3.1.3 Research and Academic Laboratories
3.1.4 Others
3.2 Global Sexually Transmitted Disease Therapeutics Market Size by Application (2017, 2022 & 2028)
3.3 Global Sexually Transmitted Disease Therapeutics Market Size by Application (2017-2028)
3.4 United States Sexually Transmitted Disease Therapeutics Market Size by Application (2017, 2022 & 2028)
3.5 United States Sexually Transmitted Disease Therapeutics Market Size by Application (2017-2028)
4 Global Sexually Transmitted Disease Therapeutics Competitor Landscape by Company
4.1 Global Sexually Transmitted Disease Therapeutics Market Size by Company
4.1.1 Top Global Sexually Transmitted Disease Therapeutics Companies Ranked by Revenue (2021)
4.1.2 Global Sexually Transmitted Disease Therapeutics Revenue by Player (2017-2022)
4.2 Global Sexually Transmitted Disease Therapeutics Concentration Ratio (CR)
4.2.1 Sexually Transmitted Disease Therapeutics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Sexually Transmitted Disease Therapeutics in 2021
4.2.3 Global Sexually Transmitted Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Sexually Transmitted Disease Therapeutics Headquarters, Revenue in Sexually Transmitted Disease Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Sexually Transmitted Disease Therapeutics Headquarters and Area Served
4.3.2 Global Sexually Transmitted Disease Therapeutics Companies Revenue in Sexually Transmitted Disease Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Sexually Transmitted Disease Therapeutics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Sexually Transmitted Disease Therapeutics Market Size by Company
4.5.1 Top Sexually Transmitted Disease Therapeutics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Sexually Transmitted Disease Therapeutics Revenue by Players (2020, 2021 & 2022)
5 Global Sexually Transmitted Disease Therapeutics Market Size by Region
5.1 Global Sexually Transmitted Disease Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Sexually Transmitted Disease Therapeutics Market Size by Region (2017-2028)
5.2.1 Global Sexually Transmitted Disease Therapeutics Market Size by Region: 2017-2022
5.2.2 Global Sexually Transmitted Disease Therapeutics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Sexually Transmitted Disease Therapeutics Market Size YoY Growth 2017-2028
6.1.2 North America Sexually Transmitted Disease Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Sexually Transmitted Disease Therapeutics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Sexually Transmitted Disease Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Sexually Transmitted Disease Therapeutics Market Size YoY Growth 2017-2028
6.3.2 Europe Sexually Transmitted Disease Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Sexually Transmitted Disease Therapeutics Market Size YoY Growth 2017-2028
6.4.2 Latin America Sexually Transmitted Disease Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Sexually Transmitted Disease Therapeutics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Sexually Transmitted Disease Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Company Details
7.1.2 Abbott Business Overview
7.1.3 Abbott Sexually Transmitted Disease Therapeutics Introduction
7.1.4 Abbott Revenue in Sexually Transmitted Disease Therapeutics Business (2017-2022)
7.1.5 Abbott Recent Development
7.2 Roche
7.2.1 Roche Company Details
7.2.2 Roche Business Overview
7.2.3 Roche Sexually Transmitted Disease Therapeutics Introduction
7.2.4 Roche Revenue in Sexually Transmitted Disease Therapeutics Business (2017-2022)
7.2.5 Roche Recent Development
7.3 BD
7.3.1 BD Company Details
7.3.2 BD Business Overview
7.3.3 BD Sexually Transmitted Disease Therapeutics Introduction
7.3.4 BD Revenue in Sexually Transmitted Disease Therapeutics Business (2017-2022)
7.3.5 BD Recent Development
7.4 BioMérieux
7.4.1 BioMérieux Company Details
7.4.2 BioMérieux Business Overview
7.4.3 BioMérieux Sexually Transmitted Disease Therapeutics Introduction
7.4.4 BioMérieux Revenue in Sexually Transmitted Disease Therapeutics Business (2017-2022)
7.4.5 BioMérieux Recent Development
7.5 Bio-Rad
7.5.1 Bio-Rad Company Details
7.5.2 Bio-Rad Business Overview
7.5.3 Bio-Rad Sexually Transmitted Disease Therapeutics Introduction
7.5.4 Bio-Rad Revenue in Sexually Transmitted Disease Therapeutics Business (2017-2022)
7.5.5 Bio-Rad Recent Development
7.6 Cepheid
7.6.1 Cepheid Company Details
7.6.2 Cepheid Business Overview
7.6.3 Cepheid Sexually Transmitted Disease Therapeutics Introduction
7.6.4 Cepheid Revenue in Sexually Transmitted Disease Therapeutics Business (2017-2022)
7.6.5 Cepheid Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
    Table 1. Sexually Transmitted Disease Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Sexually Transmitted Disease Therapeutics Market Trends
    Table 3. Sexually Transmitted Disease Therapeutics Market Drivers
    Table 4. Sexually Transmitted Disease Therapeutics Market Challenges
    Table 5. Sexually Transmitted Disease Therapeutics Market Restraints
    Table 6. Global Sexually Transmitted Disease Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Sexually Transmitted Disease Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Sexually Transmitted Disease Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Sexually Transmitted Disease Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Sexually Transmitted Disease Therapeutics Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Sexually Transmitted Disease Therapeutics Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Sexually Transmitted Disease Therapeutics Revenue Share by Player, 2017-2022
    Table 13. Global Sexually Transmitted Disease Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Sexually Transmitted Disease Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Disease Therapeutics as of 2021)
    Table 15. Top Players of Sexually Transmitted Disease Therapeutics in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Sexually Transmitted Disease Therapeutics Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Sexually Transmitted Disease Therapeutics Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Sexually Transmitted Disease Therapeutics Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Sexually Transmitted Disease Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Sexually Transmitted Disease Therapeutics Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Sexually Transmitted Disease Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Sexually Transmitted Disease Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Sexually Transmitted Disease Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Sexually Transmitted Disease Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Sexually Transmitted Disease Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Sexually Transmitted Disease Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Sexually Transmitted Disease Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Sexually Transmitted Disease Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Abbott Company Details
    Table 31. Abbott Business Overview
    Table 32. Abbott Sexually Transmitted Disease Therapeutics Product
    Table 33. Abbott Revenue in Sexually Transmitted Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 34. Abbott Recent Development
    Table 35. Roche Company Details
    Table 36. Roche Business Overview
    Table 37. Roche Sexually Transmitted Disease Therapeutics Product
    Table 38. Roche Revenue in Sexually Transmitted Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 39. Roche Recent Development
    Table 40. BD Company Details
    Table 41. BD Business Overview
    Table 42. BD Sexually Transmitted Disease Therapeutics Product
    Table 43. BD Revenue in Sexually Transmitted Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 44. BD Recent Development
    Table 45. BioMérieux Company Details
    Table 46. BioMérieux Business Overview
    Table 47. BioMérieux Sexually Transmitted Disease Therapeutics Product
    Table 48. BioMérieux Revenue in Sexually Transmitted Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 49. BioMérieux Recent Development
    Table 50. Bio-Rad Company Details
    Table 51. Bio-Rad Business Overview
    Table 52. Bio-Rad Sexually Transmitted Disease Therapeutics Product
    Table 53. Bio-Rad Revenue in Sexually Transmitted Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 54. Bio-Rad Recent Development
    Table 55. Cepheid Company Details
    Table 56. Cepheid Business Overview
    Table 57. Cepheid Sexually Transmitted Disease Therapeutics Product
    Table 58. Cepheid Revenue in Sexually Transmitted Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 59. Cepheid Recent Development
    Table 60. Research Programs/Design for This Report
    Table 61. Key Data Information from Secondary Sources
    Table 62. Key Data Information from Primary Sources
List of Figures
    Figure 1. Sexually Transmitted Disease Therapeutics Product Picture
    Figure 2. Global Sexually Transmitted Disease Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Sexually Transmitted Disease Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 4. United States Sexually Transmitted Disease Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Sexually Transmitted Disease Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 6. United States Sexually Transmitted Disease Therapeutics Market Share in Global 2017-2028
    Figure 7. Sexually Transmitted Disease Therapeutics Report Years Considered
    Figure 8. Product Picture of Gonorrhea
    Figure 9. Product Picture of Syphilis
    Figure 10. Product Picture of Chlamydia
    Figure 11. Product Picture of Trichomoniasis
    Figure 12. Global Sexually Transmitted Disease Therapeutics Market Share by Type in 2022 & 2028
    Figure 13. Global Sexually Transmitted Disease Therapeutics Market Size by Type (2017-2028) & (US$ Million)
    Figure 14. Global Sexually Transmitted Disease Therapeutics Market Share by Type (2017-2028)
    Figure 15. United States Sexually Transmitted Disease Therapeutics Market Share by Type in 2022 & 2028
    Figure 16. United States Sexually Transmitted Disease Therapeutics Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. United States Sexually Transmitted Disease Therapeutics Market Share by Type (2017-2028)
    Figure 18. Product Picture of Hospitals
    Figure 19. Product Picture of Diagnostic Laboratories
    Figure 20. Product Picture of Research and Academic Laboratories
    Figure 21. Product Picture of Others
    Figure 22. Global Sexually Transmitted Disease Therapeutics Market Share by Application in 2022 & 2028
    Figure 23. Global Sexually Transmitted Disease Therapeutics Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. Global Sexually Transmitted Disease Therapeutics Market Share by Application (2017-2028)
    Figure 25. United States Sexually Transmitted Disease Therapeutics Market Share by Application in 2022 & 2028
    Figure 26. United States Sexually Transmitted Disease Therapeutics Market Size by Application (2017-2028) & (US$ Million)
    Figure 27. United States Sexually Transmitted Disease Therapeutics Market Share by Application (2017-2028)
    Figure 28. North America Sexually Transmitted Disease Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. U.S. Sexually Transmitted Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Canada Sexually Transmitted Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Europe Sexually Transmitted Disease Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 32. Germany Sexually Transmitted Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. France Sexually Transmitted Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. U.K. Sexually Transmitted Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Italy Sexually Transmitted Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Russia Sexually Transmitted Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific Sexually Transmitted Disease Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 38. China Sexually Transmitted Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Japan Sexually Transmitted Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. South Korea Sexually Transmitted Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. India Sexually Transmitted Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Australia Sexually Transmitted Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Taiwan Sexually Transmitted Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Indonesia Sexually Transmitted Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Thailand Sexually Transmitted Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Malaysia Sexually Transmitted Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Philippines Sexually Transmitted Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Latin America Sexually Transmitted Disease Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 49. Mexico Sexually Transmitted Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Brazil Sexually Transmitted Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Argentina Sexually Transmitted Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Sexually Transmitted Disease Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 53. Turkey Sexually Transmitted Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Sexually Transmitted Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. U.A.E Sexually Transmitted Disease Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Abbott Revenue Growth Rate in Sexually Transmitted Disease Therapeutics Business (2017-2022)
    Figure 57. Roche Revenue Growth Rate in Sexually Transmitted Disease Therapeutics Business (2017-2022)
    Figure 58. BD Revenue Growth Rate in Sexually Transmitted Disease Therapeutics Business (2017-2022)
    Figure 59. BioMérieux Revenue Growth Rate in Sexually Transmitted Disease Therapeutics Business (2017-2022)
    Figure 60. Bio-Rad Revenue Growth Rate in Sexually Transmitted Disease Therapeutics Business (2017-2022)
    Figure 61. Cepheid Revenue Growth Rate in Sexually Transmitted Disease Therapeutics Business (2017-2022)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4350
This license allows only one user to access the PDF.

Electronic (PDF)
$6525
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$8700
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global and United States Auto Refractor Market Insights Forecast to 2027
Global Auto Refractor Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-17Z7620
Fri Aug 12 00:00:00 UTC 2022

Add to Cart

Global IVF Time lapse Imaging Devices Market Research Report 2022
Global IVF Time-lapse Imaging Devices Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-21A11618
Fri Aug 12 00:00:00 UTC 2022

Add to Cart

Global and United States Estrogen Market Insights Forecast to 2027
Global Estrogen Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-23W7191
Fri Aug 12 00:00:00 UTC 2022

Add to Cart

Global Medical Fluoropolymers Market Research Report 2022
Global Medical Fluoropolymers Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-30P11376
Fri Aug 12 00:00:00 UTC 2022

Add to Cart